Page 3 - Jazz Pharmaceuticals Stock Down News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jazz pharmaceuticals stock down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jazz Pharmaceuticals Stock Down Today - Breaking & Trending Today

StockNews.com Downgrades Jazz Pharmaceuticals (NASDAQ:JAZZ) to Buy

StockNews.com lowered shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) from a strong-buy rating to a buy rating in a report released on Thursday. A number of other research analysts have also recently commented on the stock. Cantor Fitzgerald reiterated an overweight rating and set a $180.00 price target on shares of Jazz Pharmaceuticals in […] ....

United States , Neenam Patil , Securities Exchange Commission , Needham Company , Institutional Trading Of Jazz Pharmaceuticals , Royal Bank , Morgan Stanley , Analyst Recommendations For Jazz Pharmaceuticals , Jazz Pharmaceuticals , Manufacturers Life Insurance Company , Jazz Pharmaceuticals Stock Down , Insider Transactions At Jazz Pharmaceuticals , Jazz Pharmaceuticals Company Profile , Cantor Fitzgerald , News Ratings For Jazz Pharmaceuticals Daily , Free Report , Moderate Buy , Pharmaceuticals Stock Down , Exchange Commission , Get Free Report , Jazz Pharmaceuticals Daily , Nasdaq Jazz , Stocknews Com ,

Raymond James Begins Coverage on Jazz Pharmaceuticals (NASDAQ:JAZZ)

Raymond James assumed coverage on shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) in a research report sent to investors on Thursday morning, Marketbeat reports. The firm issued a market perform rating on the specialty pharmaceutical company’s stock. Several other equities research analysts have also issued reports on JAZZ. Royal Bank of Canada dropped their […] ....

United States , Ricke Winningham , Raymond James , Neenam Patil , Royal Bank , V Square Quantitative Management , Institutional Investors Weigh In On Jazz Pharmaceuticals , Jazz Pharmaceuticals , St Germaindj Co , Needham Company , News Ratings For Jazz Pharmaceuticals Daily , Securities Exchange Commission , Jazz Pharmaceuticals Stock Down , Cantor Fitzgerald , Analyst Recommendations For Jazz Pharmaceuticals , Quadrant Capital Group , Free Report , Pharmaceuticals Stock Down , Get Free Report , Director Rick , Exchange Commission , Wealth Management , Square Quantitative Management , Capital Group , Jazz Pharmaceuticals Daily , Nasdaq Jazz ,

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Receives $206.67 Consensus Target Price from Analysts

Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) have earned an average recommendation of “Buy” from the six brokerages that are covering the firm, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average twelve-month price objective among brokers that have issued ratings on the stock […] ....

United States , Neenam Patil , Jazz Pharmaceuticals Stock Down , St Germaindj Co , Needham Company , Analyst Recommendations For Jazz Pharmaceuticals , News Ratings For Jazz Pharmaceuticals Daily , Jazz Pharmaceuticals , Jazz Pharmaceuticals Company Profile , Insider Transactions At Jazz Pharmaceuticals , Institutional Investors Weigh In On Jazz Pharmaceuticals , Delphi Management Inc , Cantor Fitzgerald , Barclays Plc , Get Free Report , Marketbeat Ratings , Retirement Systems , Teachers Retirement System , Retirement System , Pharmaceuticals Stock Down , Get Free , Jazz Pharmaceuticals Daily , Nasdaq Jazz ,

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Profund Advisors LLC

Profund Advisors LLC reduced its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 7.6% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 6,475 shares of the specialty pharmaceutical company’s stock after selling 532 shares during the quarter. Profund […] ....

United States , Ricke Winningham , Neenam Patil , Profund Advisors , Huntington National Bank , Advisors Inc , Insider Transactions At Jazz Pharmaceuticals , Jazz Pharmaceuticals , News Ratings For Jazz Pharmaceuticals Daily , Cantor Fitzgerald , Jazz Pharmaceuticals Company Profile , Jazz Pharmaceuticals Stock Down , Archer Investment Corp , Royal Bank , Needham Company , Quarter For Jazz Pharmaceuticals , Free Report , Wealth Management , National Bank , Investment Corp , Pharmaceuticals Stock Down , Get Free Report , Director Rick , Jazz Pharmaceuticals Daily , Nasdaq Jazz , Sec Filings ,

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Position Trimmed by Picton Mahoney Asset Management

Picton Mahoney Asset Management lowered its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 24.3% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 655 shares of the specialty pharmaceutical company’s stock after selling 210 shares during the period. Picton Mahoney Asset Management’s […] ....

United States , Neenam Patil , Jazz Pharmaceuticals Stock Down , Needham Company , S Capital Wealth Advisors , Royal Bank , Jazz Pharmaceuticals , Advisors Inc , Quarter For Jazz Pharmaceuticals , Quadrant Capital Group , Huntington National Bank , News Ratings For Jazz Pharmaceuticals Daily , Jazz Pharmaceuticals Company Profile , Insider Transactions At Jazz Pharmaceuticals , Cantor Fitzgerald , Picton Mahoney Asset Management , Free Report , Mahoney Asset Management , National Bank , Wealth Advisors , Capital Group , Pharmaceuticals Stock Down , Get Free Report , Visit Holdingschannel , Jazz Pharmaceuticals Daily , Nasdaq Jazz ,